Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism

Watts, N. B., Bilezikian, J. P., Bone, H. G., Clarke, B. L., Denham, D., Levine, M. A., Mannstadt, M., Peacock, M., Rothman, J. G., Vokes, T. J., Warren, M. L., Yin, S., Sherry, N., & Shoback, D. M. (2023). Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism. Journal of the Endocrine Society, 7(5). https://doi.org/10.1210/jendso/bvad043
Authors:
Nelson B. Watts
John P. Bilezikian
Henry G. Bone
Bart L. Clarke
Douglas Denham
Michael A. Levine
Michael Mannstadt
Munro Peacock
Jeffrey G. Rothman
Tamara J. Vokes
Mark L. Warren
Shaoming Yin
Nicole Sherry
Dolores M. Shoback
Affiliated Authors:
John P. Bilezikian
Columbia Affiliation:
Author Keywords:
active vitamin d
bone turnover
calcium
hypoparathyroidism
mineral homeostasis
recombinant human parathyroid hormone (1-84)
elink
Publication Type:
Article
Unique ID:
10.1210/jendso/bvad043
DOI:
10.1210/jendso/bvad043
Journal:
Journal of the Endocrine Society
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record

Record Created: